Pharmaceutical

Medicxi and Starpharma to develop dendrimer-based cancer treatments

Medicxi has partnered with Starpharma for the formation of Petalion Therapeutics to develop dendrimer-based oncology treatments.

Apr 9, 2024 - 00:00
Medicxi and Starpharma to develop dendrimer-based cancer treatments
Medicxi has partnered with Starpharma for the formation of Petalion Therapeutics to develop dendrimer-based oncology treatments.
Read the original article

Tags:

Previous Article

AdAlta and SYNthesis to form AdCella for advanced cancer treatments

Next Article

BMS and 2seventy bio’s Abecma gains approval for multiple myeloma

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: A targeted therapy shows it can offer a ‘last, great chance’ for some acute leukemia patients

STAT+: A targeted therapy shows it can offer a ‘last, g...

Dec 13, 2023

India’s Cipla signs licence deal with Novartis for diabetes drug Galvus

India’s Cipla signs licence deal with Novartis for diab...

Apr 10, 2023

Idorsia sells off its Asia Pacific operations to raise funds

Idorsia sells off its Asia Pacific operations to raise ...

Jul 21, 2023